Therapies

AveXis Inc.: Senior Training Specialist

6 days ago   |   By San Diego Biotechnology

AveXis Inc.:
OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene
San Diego, CA, US
...
Read more ...

 

Tocagen: Associate Director, Quality Assurance

6 days ago   |   By San Diego Biotechnology

Tocagen:
Function/Scope:The Associate Director, Quality Assurance will establish, maintain, and ensure effectiveness of quality operations and systems to assur
San Diego, CA, United States
...
Read more ...

 

Sr. Manager, Clinical Supplies - Intercept Pharmaceuticals - San Diego, CA

6 days ago   |   By San Diego Biotechnology

Minimum 5 years' experience in the pharma/biotech industry. Design, configure, and review IRT systems for drug supply management, accountability, and...From Intercept Pharmaceuticals - Wed, 11 Sep 2019 05:35:24 GMT - View all San Diego, CA jobs...
Read more ...

 

Oncology Specialty Consultant - San Diego - Bayer - San Diego, CA

6 days ago   |   By San Diego Biotechnology

Minimum of five (5) years of pharmaceutical, biotech, medical selling experience or oncology medical experience equivalent;From Bayer - Wed, 11 Sep 2019 04:35:24 GMT - View all San Diego, CA jobs...
Read more ...

 


Search by Tags

   Therapies      Gene      Genes      Neurology      San Diego Biotech Jobs      Pharma      Industrial      Drugs      Pharmaceutical      Biotech      BioTech      Pharmaceuticals      BioTech Industry      Drug      Clinical  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Why Menlo Ventures Backed Its First Construction Tech Firm

Why Menlo Ventures Backed Its First Construction Tech Firm

Fieldwire , whose mobile app helps builders and construction crews coordinate their work, announced today it has lined up a total of $33.5 million across two newly disclosed... Read more ...

HMS's $36M Deal to Buy VitreosHealth Combines Complementary Firms

HMS's $36M Deal to Buy VitreosHealth Combines Complementary Firms

One Texas-based healthcare software business has acquired another in an all-cash deal worth $36.5 million, the companies announced late Monday. Irving, TX-based HMS Holdings... Read more ...

ESnet a Key Partner on Project to Build Novel Network Research Infrastructure

ESnet a Key Partner on Project to Build Novel Network Research Infrastructure

Anticipated FABRIC topology at the end of construction. The National Science Foundation is funding a collaborative effort to create a nationwide research infrastructure that... Read more ...

Automated Trucking Company TuSimple Adds $120M More From Investors

Automated Trucking Company TuSimple Adds $120M More From Investors

UPS, the global package delivery giant, took a minority stake this summer in TuSimple, a self-driving trucking company, but didn't reveal financial details. On Tuesday, the San... Read more ...

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Pharmaceuticals, which is testing a new type of drug against life-threatening infections acquired by patients with compromised immune systems, has acquired the rights to... Read more ...

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Denmark's neuroscience-focused pharma firm Lundbeck has agreed to pay $1.95 billion to acquire Seattle-based Alder BioPharmaceuticals to boost its late-stage pipeline and... Read more ...

KATRIN Cuts the Mass Estimate for the Elusive Neutrino in Half

KATRIN Cuts the Mass Estimate for the Elusive Neutrino in Half

A diagram of the layout and major features of the KATRIN experimental facility at the Karlsruhe Institute of Technology. (Credit: Karlsruhe Institute of Technology) Note: This... Read more ...

INmune Bio Invited to Speak on Company's Advancements in Cancer Treatments...

La Jolla, CA., Sept. 17, 2019 - INmune Bio, Inc. , an immunology company focused on developing treatments that harness the patient's innate immune system to fight disease... Read more ...

Equillium to Host Business Update Call on October 1, 2019

LA JOLLA, Calif., Sept. 17, 2019 - Equillium, Inc. , a clinical-stage biotechnology company, leveraging deep understanding of immunobiology to develop products to treat severe... Read more ...

AXIM® Biotechnologies Announces Cultivation Agreement to Establish Company's...

SAN DIEGO, Sept. 17, 2019 - AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”) , a world leader in cannabinoid research and development, today announced... Read more ...